Harvard Bioscience, Inc. (HBIO) Q3 EPS Drops to 5c; Revs Flat

Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q3 EPS of $0.05, versus $0.08 reported last year. Revenue for the quarter came in at $26.38 million, versus $26.45 million reported last year.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Harvard Bioscience (HBIO) PT Raised to $7.50 at Benchmark on Q2 Beat and Raise
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M